EPO and renal fibrosis: Furthermore, activation of the erythropoietin (EPO) signaling pathway has been demonstrated to reduce oxidative stress and mitochondrial activity, thereby inhibiting the accumulation of bone marrow–derived fibrocytes and alleviating renal fibrosis [124,125].